These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35608185)

  • 1. A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes.
    Liu R; Cao Z; Pan M; Wu M; Li X; Yuan H; Liu Z
    Cancer Med; 2022 Dec; 11(23):4703-4720. PubMed ID: 35608185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma.
    Liu R; Cao Z; Wu M; Li X; Fan P; Liu Z
    BMC Med Genomics; 2023 Mar; 16(1):60. PubMed ID: 36973751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
    Wu M; Yuan H; Li X; Liao Q; Liu Z
    Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
    Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
    Chen S; Zhao E
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
    Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
    Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
    Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
    BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.
    Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ
    Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
    Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
    Front Immunol; 2021; 12():805883. PubMed ID: 35095892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell cycle-related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma.
    Li S; Ran MY; Qiao H
    Front Endocrinol (Lausanne); 2023; 14():1110987. PubMed ID: 36923215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
    Wang L; Yao B; Yang J; Tian Z; He J
    BMC Cancer; 2022 Nov; 22(1):1131. PubMed ID: 36333684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer.
    Ding Y; Li P; Wang W; Liu F
    Dis Markers; 2022; 2022():8735551. PubMed ID: 36193505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMT-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Hepatocellular Carcinoma.
    Cao D; Liu H; Bai L; Tang H
    Dig Dis; 2023; 41(2):282-295. PubMed ID: 35636408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wen J; Lin B; Lin L; Chen Y; Wang O
    Aging (Albany NY); 2020 Aug; 12(16):16437-16456. PubMed ID: 32857728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.
    Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
    BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells.
    Pratheeshkumar P; Siraj AK; Divya SP; Parvathareddy SK; Alobaisi K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
    Zhang D; Zhou S; Liu B
    Biomed Res Int; 2020; 2020():7082408. PubMed ID: 32309437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.
    Qian X; Tang J; Li L; Chen Z; Chen L; Chu Y
    Bioengineered; 2021 Dec; 12(1):2341-2351. PubMed ID: 34077308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.